Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer

Download real time

989.95 -2.15 (-0.22%)

288.3K

NSE+BSE Volume

NSE 30 Sep, 2025 11:30 AM (IST)

Zydus Lifesciences Ltd. share price target

Zydus Lifesciences Ltd. has an average share price target of 1045.33. The consensus estimate represents an upside of 5.59% from the last price of 989.95. View 13 reports from 6 analysts offering long-term price targets for Zydus Lifesciences Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	30 Sep 2025	Zydus Lifesciences	Consensus Share Price Target	989.95	1017.50	-	2.78	hold	pdf Detailed Estimates
	17 Feb 2023	Zydus Lifesciences	Geojit BNP Paribas Reco Target	989.95	528.00	470.65 (110.34%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES LIMITED Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Zydus Lifesciences	ICICI Securities Limited Target	989.95	482.00	434.65 (127.76%)	Target met	Accumulate	pdf post cache		Broker Report Beats expectations; US launches to support growth ICICI Securities Limited Zydus Lifesciences’ (Zydus) reported Q3FY23 performance exceeded our estimates on all fronts. Revenues grew 19.4% YoY to Rs43.6bn (I-Sec: Rs40.7bn) driven by India and US markets. pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Zydus Lifesciences	Prabhudas Lilladhar Target	989.95	480.00	470.15 (110.56%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Zydus Lifesciences	Motilal Oswal Target	989.95	460.00	434.00 (128.10%)	Target met	Neutral	pdf post cache		Broker Report Strong traction in India/US drives earnings growth Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Zydus Lifesciences	ICICI Direct Reco Target	989.95	500.00	434.65 (127.76%)	Target met	Buy	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	02 Jan 2023	Zydus Lifesciences	Ashika Research	989.95	480.00	420.10 (135.65%)	Target met	Buy	pdf post cache		Broker Report Ashika - Stock Picks Zydus Lifesciences Ltd. - January 2023 Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	ICICI Direct Target	989.95	480.00	423.80 (133.59%)	Target met	Hold	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	Prabhudas Lilladhar Reco Target	989.95	465.00	416.75 (137.54%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	ICICI Securities Limited Target	989.95	448.00	423.80 (133.59%)	Target met	Hold	pdf post cache		Broker Report Moraiya cleared; Revlimid launched ICICI Securities Limited Zydus Lifesciences (Zydus) reported Q2FY23 performance is broadly in line with our estimates. Revenue grew 7.3% YoY to Rs40.0bn (I-Sec: Rs40.0bn) on the back of India and US markets. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2022	Zydus Lifesciences	Motilal Oswal Reco Target	989.95	410.00	423.80 (133.59%)	Target met	Neutral	pdf post cache		Broker Report India and US drives while Consumer Wellness and API drag earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners